Compare · PRVA vs SBC
PRVA vs SBC
Side-by-side comparison of Privia Health Group Inc. (PRVA) and SBC Medical Group Holdings Incorporated (SBC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PRVA and SBC operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.73B, about 8.8x SBC ($309.6M).
- PRVA has been more active in the news (11 items in the past 4 weeks vs 6 for SBC).
- PRVA has more recent analyst coverage (25 ratings vs 1 for SBC).
- Company
- Privia Health Group Inc.
- SBC Medical Group Holdings Incorporated
- Price
- $21.63+1.22%
- $3.01-1.15%
- Market cap
- $2.73B
- $309.6M
- 1M return
- -
- -6.38%
- 1Y return
- -
- -41.10%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2022
- News (4w)
- 11
- 6
- Recent ratings
- 25
- 1
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest PRVA
- Privia Health Enters New Jersey
- Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)
- Director Berberian Lance was granted 8,463 shares, increasing direct ownership by 110% to 16,131 units (SEC Form 4)
- Director Cocozza Nancy G was granted 8,463 shares, increasing direct ownership by 25% to 42,814 units (SEC Form 4)
- Director Kimmet Pamela O was granted 8,463 shares, increasing direct ownership by 33% to 34,172 units (SEC Form 4)
- Director Mccarthy Thomas A was granted 8,463 shares, increasing direct ownership by 43% to 27,983 units (SEC Form 4)
- Director King David P was granted 8,463 shares, increasing direct ownership by 20% to 50,775 units (SEC Form 4)
- Director Ryu Jaewon was granted 8,463 shares, increasing direct ownership by 22% to 47,110 units (SEC Form 4)
- Director Morris Matthew Shawn was granted 8,463 shares, increasing direct ownership by 12% to 76,651 units (SEC Form 4)
- SEC Form 3 filed by new insider Soistman Francis S Jr
Latest SBC
- SEC Form DEFA14A filed by SBC Medical Group Holdings Incorporated
- SEC Form DEF 14A filed by SBC Medical Group Holdings Incorporated
- SBC Medical will participate in several upcoming investor conferences in May and June 2026
- SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
- SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Leadership Update
- Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
- SEC Form PRE 14A filed by SBC Medical Group Holdings Incorporated
- SEC Form 10-Q filed by SBC Medical Group Holdings Incorporated
- SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SBC Medical Group Holdings Announces First Quarter 2026 Financial Results